
Ajanta Pharmaceuticals Ltd. share price
NSE: AJANTPHARM · Healthcare
₹3,360.60 +2.33%
Closing price data, updated 17 Nov 2026. 52-week range: -11.5% from high, +37.4% above low.
Price₹3,360.60
Market cap₹41,994 Cr
P/E33.2
P/B8.64
ROE25.4%
ROCE29.4%
Debt / equity0.06
Dividend yield0.00%
EPS₹101.06
Book value₹388.79
Operating margin24.5%
Dipscan score65 / 100
Share: WhatsAppX / TwitterTelegram
Ajanta Pharmaceuticals Ltd. shareholding pattern
As of Sep 2026: Promoters 63.47%, FIIs 7.63%, DIIs 21.94%, Government 0.00%, Public 6.21%, Others 0.75%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 63.47% | 63.48% | 66.25% | 66.25% | 66.25% | 66.26% |
| FIIs | 7.63% | 7.68% | 8.26% | 7.98% | 8.53% | 8.86% |
| DIIs | 21.94% | 21.80% | 18.37% | 18.58% | 17.90% | 17.50% |
| Government | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 6.21% | 6.27% | 6.35% | 6.44% | 6.53% | 6.59% |
| Others | 0.75% | 0.76% | 0.77% | 0.76% | 0.79% | 0.79% |
| No. of Shareholders | 61,923 | 65,296 | 67,955 | 65,409 | 67,785 | 68,882 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +2.33% | +1.60% | +1.87% | -7.03% | +3.11% | +32.89% |
Growth
| Sales growth, 3 years | +13.4% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +21.6% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | – |
| Latest quarter profit vs last year | – |
Strengths and weaknesses
Strengths
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.2%
- Company has been maintaining a healthy dividend payout of 50.1%
Weaknesses
- Stock is trading at 8.64 times its book value
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Ajanta Pharmaceuticals Ltd.?
Ajanta Pharmaceuticals Ltd. (AJANTPHARM) last closed at ₹3,360.60 (+2.33% on the day).
What is the market cap of Ajanta Pharmaceuticals Ltd.?
About ₹41,994 Cr.
What is the P/E ratio of Ajanta Pharmaceuticals Ltd.?
The price-to-earnings ratio is 33.2, and return on equity is 25.4%.
Figures are calculated from company results and exchange prices and are for information only.